(Q46337615)

21 December 2017

title

Safety and tolerability of inhaled hypertonic saline in young children with cystic fibrosis (English)

1 reference

21 December 2017

0 references

Elisabeth P Dellon

1

1 reference

21 December 2017

Scott H Donaldson

series ordinal

2

1 reference

21 December 2017

Robin Johnson

series ordinal

3

1 reference

21 December 2017

Stephanie D Davis

series ordinal

4

1 reference

21 December 2017

publication date

1 November 2008

1 reference

21 December 2017

published in

Pediatric Pulmonology

1 reference

21 December 2017

volume

43

1 reference

21 December 2017

issue

11

1 reference

21 December 2017

page(s)

1100-1106

1 reference

21 December 2017

CFTR as a cAMP-dependent regulator of sodium channels

cites work

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.20909

Evidence for airway surface dehydration as the initiating event in CF airway disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.20909

Evidence for periciliary liquid layer depletion, not abnormal ion composition, in the pathogenesis of cystic fibrosis airways disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.20909

Increased airway epithelial Na+ absorption produces cystic fibrosis-like lung disease in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.20909

Inflammation, infection, and pulmonary function in infants and young children with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.20909

Computed tomography reflects lower airway inflammation and tracks changes in early cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.20909

Structural airway abnormalities in infants and young children with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.20909

High-resolution computed tomography imaging of airway disease in infants with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.20909

Lower airway inflammation in infants with cystic fibrosis detected by newborn screening.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.20909

Effect of increasing doses of hypertonic saline on mucociliary clearance in patients with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.20909

Sputum induction as a research tool for sampling the airways of subjects with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.20909

Clinical value of obtaining sputum and cough swab samples following inhaled hypertonic saline in children with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.20909

Safety and use of sputum induction in children with cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.20909

Short-term efficacy of ultrasonically nebulized hypertonic saline in cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.20909

Mucus clearance and lung function in cystic fibrosis with hypertonic saline

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.20909

A controlled trial of long-term inhaled hypertonic saline in patients with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.20909

Hypertonic saline and recombinant human DNase: a randomised cross-over pilot study in patients with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.20909

Pilot study of safety and tolerability of inhaled hypertonic saline in infants with cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.20909

Airway inflammation in children with cystic fibrosis and healthy children assessed by sputum induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.20909

Inflammatory and microbiologic markers in induced sputum after intravenous antibiotics in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.20909

Analysis of sequential aliquots of hypertonic saline solution-induced sputum from clinically stable patients with cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.20909

An official American Thoracic Society/European Respiratory Society statement: pulmonary function testing in preschool children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.20909

Forced expiratory flows and volumes in infants. Normative data and lung growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.20909

Adult-type pulmonary function tests in infants without respiratory disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.20909

Safety and tolerability of denufosol tetrasodium inhalation solution, a novel P2Y2 receptor agonist: results of a phase 1/phase 2 multicenter study in mild to moderate cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.20909

Inhalation of Moli1901 in patients with cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.20909

Osmotic stimuli increase clearance of mucus in patients with mucociliary dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.20909

Nebulized 3% hypertonic saline solution treatment in hospitalized infants with viral bronchiolitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.20909

Nebulized 3% hypertonic saline solution treatment in ambulatory children with viral bronchiolitis decreases symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.20909

21 January 2018

Identifiers

DOI

10.1002/PPUL.20909

1 reference

21 December 2017

1 reference

21 December 2017